NCT04859348

Brief Summary

Gestational diabetes mellitus (GDM) GDM is the most common complication that affects the health of the child and mother during pregnancy. Objectives was to determine the effects of Antenatal exercises on glucose levels, mode of delivery and APGAR Score in females with gestational diabetes mellitus. This Randomized controlled trial study was conducted on N= 72 pregnant females at department of Gynecology and Obstetrics, Mian Munshi DHQ Hospital, Lahore after Ethical approval of synopsis from institutional Review Board of the University of Lahore . The data was entered and analyzed using SPSS Version 24. .

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2020

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 16, 2021

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

April 21, 2021

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 26, 2021

Completed
Last Updated

April 26, 2021

Status Verified

April 1, 2021

Enrollment Period

4 months

First QC Date

April 21, 2021

Last Update Submit

April 21, 2021

Conditions

Keywords

Antenatal ExerciseAPGAR ScoreC-sectionMode of deliveryPregnancy

Outcome Measures

Primary Outcomes (3)

  • Glucose level

    Effect of antenatal exercise on glucose level was measured by test beta HbAc1 performed by gynecology department before delivery

    4 months

  • mode of delivery

    effect of antenatal exercise on type of delivery was studied as it was normal vaginal or caesarian section

    4 months

  • APGAR Score

    effect of antenatal exercise on APGAR score was studied which describe fetal health after delivery

    4 months

Study Arms (2)

Group-A ( RPT+ Insulin Therapy)

EXPERIMENTAL

Group A includes participants received the routine physical therapy only.

Other: routine physical therapy

Group-B (RPT+ Antenatal Exercises+ Insulin therapy)

EXPERIMENTAL

Group B includes participants were given antenatal exercise program from 20- 24 weeks of gestation to till the date of delivery, with addition of the routine physical therapy plan.

Other: routine physical therapy and antenatal exercises

Interventions

G- A 36 participants received only routine treatment for GDM which includes insulin therapy and diet control guided by gynecologist and routine physical therapy which includes walk for 1 hr with proper warm up and cool down periods, three times in a week from 20-24 weeks of gestation to till delivery.

Group-A ( RPT+ Insulin Therapy)

G- B 36 participants receive routine therapy (insulin therapy and diet control) and Aerobic and strengthening Exercises for 3 days a week, for 2 weeks 6 sessions under the supervision of physiotherapist and remaining was performed at home. Exercise was started from 15 min and reach to 30 mins gradually.10-15-minute warm-up, cool-down period was included by using ACOG Guideline. Aerobic exercise includes a brisk walk and strengthening exercise were performed with hold for 5 seconds and 10 repetitions. Exercise should stop if they experience any signs of dizziness, dyspnea, amniotic fluid leaking or vaginal bleeding. Confidentiality and blindness ensure by random allocation.

Group-B (RPT+ Antenatal Exercises+ Insulin therapy)

Eligibility Criteria

Age20 Years - 35 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Panel patients who are covered under medical facility provided by the company
  • Booked cases
  • Participant's Borg scale score 6 to 14
  • Age 20-35 years
  • weeks of gestation
  • Diagnosed case of GDM
  • Primigravida
  • BMI does not exceed 40 kg/m²

You may not qualify if:

  • Females diagnosed with vascular complications (Preeclampsia, hemolysis etc.)
  • Uncontrolled diabetes mellitus
  • Autonomic dysfunction /Peripheral neuropathy (Damage to the nerves outside of the brain and spinal cord which effect sensations)
  • Nephropathy or retinopathy (Damage to the small blood vessels of kidneys and eyes)
  • Twins fetus
  • Placenta Previa (placenta partially or totally covers the mother's cervix)
  • Fetal anomalies
  • Female choice for caesarean section
  • Intrauterine growth retardation (fetal complication)
  • Short cervix length
  • Antepartum hemorrhage (bleeding from the genital tract)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Anumsattar8@Gmail.Com

Lahore, Punjab Province, 54000, Pakistan

Location

MeSH Terms

Conditions

Diabetes, Gestational

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDiabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Anum Sattar, MPhil

    student

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
outcomes accessor donot know the type of intervention given to patient not during evaluation or data record
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: G- A 36 participants received only routine treatment for GDM G- B 36 participants receive routine therapy (insulin therapy and diet control) and Aerobic and strengthening Exercises.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 21, 2021

First Posted

April 26, 2021

Study Start

November 1, 2020

Primary Completion

March 1, 2021

Study Completion

April 16, 2021

Last Updated

April 26, 2021

Record last verified: 2021-04

Data Sharing

IPD Sharing
Will share

all collected data will be share.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
December 2021 data will available approximately
Access Criteria
Any one can access the data
More information

Locations